Using mathematical models to simulate dynamic biological processes has a long history.
Introduction
Mathematical modeling is a powerful tool to test hypotheses, confirm experiments, and simulate the dynamics of complex systems. In addition to helping understand the mechanistic underpinnings of dynamical systems, mathematical models simulate complex systems in a relatively fast time without the enormous costs of laboratory experiments and the corresponding biological variations. In particular for oncology, such models can be calibrated using experimental or clinical data [1] [2] [3] , and competing hypotheses of tumor progression can be evaluated and treatment options thoroughly analyzed before clinical intervention [4] [5] [6] [7] [8] . Techniques for quantitative modeling are plentiful, and an increasing number of theoretical approaches are successfully applied to cancer biology. Differential equation models and individual-based cell models paved the way into quantitative cancer biology about two decades ago. Herein we will give an introduction on how such models are derived and how they can be utilized to simulate tumor growth and treatment response. We will then discuss a number of different models and discuss their confirmative and predictive power for cancer biology.
Ordinary differential equation models of tumor growth
The number of cancer cells in a tumor is difficult to estimate due to constant changes in where α and β are respectively understood as the fraction of dividing and dying cells each dt, and hence denote the per capita growth and death rates of the total cell population. It is obvious that the cell number must increase after a proliferative event and decrease after a cell death event. Let us introduce variable c as number of cells. The difference in cell number then becomes dc, and the above equation can be written as:
Such equation is called an ordinary differential equation (ODE).
Let us assume that at time t=0, i.e., the starting point of an experiment, we have one million cells, i.e. c=10 6 . Population growth dynamics can follow one of three fates: (i) if α = β, then dc/dt = 0. In this case the number of cells in the population does not change and the population exhibits a state of tumor dormancy. It is of note that either α = β = 0, that is all cells in the population are in state of cellular dormancy or quiescence, or α = β >0 in which case cell proliferation is balanced by cell death [9, 10] . If (ii) α > β, then dc/dt > 0 and the cell population will continuously grow with greater α-β rates yielding faster growth. On the other hand, the population will monotonically decrease if (iii) α < β and thus dc/dt < 0 (figure 1). 
As before, if λ<0, λ=0, or λ>0 the population decreases, remains at a constant size, or increases respectively. Experimental data from in vitro or in vivo population studies can then be used to parameterize such model (figure 2). 
Dynamic tumor growth rates
Defining a constant per capita growth rate to model tumor growth yields exponentially growing cell populations and neglects carrying capacity constraints. Solid tumors initially grow rapidly, but growth decelerates as tumors grow bigger [11] [12] [13] [14] . Therefore, the per capita rate of tumor growth should depend on the tumor size c and not remain constant
A classic example of a per capita rate of tumor growth dependent on tumor size relative to the host carrying capacity K is given by the logistic model
Here, (2) above. As the population grows and approaches the carrying capacity K, however,
( →0 and population growth is impeded. Figure 3 shows the evolution of population size as well as the growth rate dependent on population size relative to K for different parameters λ. Numerous dynamic growth rate functions with applicability to tumor growth have been discussed [14, 15] . The so-called Gompertz curve [17] has been shown to be applicable to biological growth that decelerates with population size [18] , and therefore to observed tumor growth slowdown with tumor size [11, 12, 19, 20] . The growth rate is the negative logarithm of the current population size divided by the carrying capacity:
Despite a more rapid growth rate fall-off, population growth mimics that observed with eqn. (3) In a pathological setting, the carrying capacity itself can be non-constant. Increase in cell mass and physical pressure may yield deformation and expansion of basement membranes thereby increasing the spatial carrying capacity dependent on tumor size.
Tumor growth, however, can also stall in absence of necessary growth factors and nutrients provided by the host vasculature. During vascular dormancy the diffusion of oxygen and nutrients into the tumor interior is limited resulting in a balance of cell proliferation and cell death [9] . The carrying capacity then defines the maximum tumor size that can be supported by vascular supply. 
In the simplest case, anti-tumor treatment induces a continuous tumor cell kill with strength 0≤ξ≤1, conceivable as chemotherapy or immunotherapy. Figure 6 shows the response of the tumor to such cell kill with different strengths after the tumor has grown for 40 days (c.f. Figure 5 ). Hahnfeldt and colleagues [21] modeled the inhibition of angiogenesis due to administered anti-angiogenic agents to be proportional to the concentration of the drug g(t), which includes partially cleared drug concentrations from previous administrations
where a(t') and clr(t-t') are the rates at which the inhibitor concentration is administered and its clearance rate, respectively. Perhaps the first spatial model of cancer invasion was developed by Gatenby and
Gawlinski [22] (inspired by previous work of Gatenby [23] 
where D c is the (constant) diffusion coefficient, ρ the (constant) cancer cell proliferation rate, δ the (constant) H + ions production rate (also taken to be equal to the decay rate) and γ the (constant) extracellular matrix degradation rate. As can be seen from the above equations, the cancer cells proliferate and undergo nonlinear diffusion (dependent on the density of normal tissue -high density of normal tissue giving lower diffusion, low density of normal tissue giving higher diffusion) and secrete H + ions, which diffuse and degrade the normal tissue. The H + ions also undergo linear decay and the normal tissue is assumed to have logistic growth in order to attain its healthy state in the absence of cancer cells (in the model of Gatenby and Gawlinski, the production and decay of H + ions is assumed to have the same rate for algebraic simplicity). For details on the mathematical formulation of diffusion, the population-level description of random cell migration, we refer the interested reader to partial differential equation textbooks.
Through a combination of computational simulation and mathematical analysis (travelling wave theory) of the aforementioned system of partial differential equations, Gatenby and Gawlinski predicted the existence of a hypocellular gap at the interface between the normal and cancerous tissue [22] . This was subsequently observed in hematoxylin-eosin (H&E) stained micrographs of invading cancers (Fig. 8) . Perumpanani et al. [24] was the first to do this. Once again through a combination of computational simulations and travelling wave analysis, predictions were made of the speed and depth of penetration of cancer cells into the host tissue. The role of haptotaxis was especially studied in the paper of Anderson et al. [25] , where a 2-dimensional setting was first used and the influence of the tissue (extracellular matrix) was explicitly explored:
In this continuum model, cell proliferation was not included in order to focus solely on the role of cancer cell migration in invasion. However, later in that paper Other continuum approaches (i.e. various PDE models) include that of Chaplain and Lolas [27] and Andasari et al. [28] (investigating in more detail the effects of the degrading enzymes, specifically the urokinase plasminogen system), Frieboes et al. [29] (focusing on cell-cell adhesion and a moving boundary approach), and Gerisch and
Chaplain [30] and Chaplain et al. [31] (using a continuum model incorporating cell-cell adhesion via a non-local integral term).
Discrete models of tumor growth
In addition to being the first 2-dimensional continuum model of cancer invasion focusing on the role of haptotaxis, the paper of Anderson et al. [25] was also the first to consider a discrete model of cancer cell invasion (now also including proliferation at a discrete level), derived from the continuum PDE model. The computational simulation results of this model explored the observation that individual cancer cells can migrate beyond a "visible margin" of cancerous tissue, which was "detectable" by surgeons. This was perhaps the first paper to explore the issue of stochastic events and probability in invasion models. Figure 9 shows a sample result of a computation simulation of the discrete model in a 2-dimensional domain. The individual cancer cells are secreting degrading enzymes and proliferating and migrating into the space created (through diffusion and haptotaxis).
As can be seen from the figure, because of the stochastic nature of the discrete model individual cancer cells possess mathematically the ability to penetrate the normal tissue at a greater depth than would be predicted usual a deterministic PDE model. Other discrete models of invasion have subsequently been developed using a variety of techniques such as the Potts Model [32, 33] , cellular automata and agent-based models [34] [35] [36] , hybrid continuum-discrete approaches [26, 37] and individual, forcebased models [38, 39] . One advantage discrete models have over continuum models, is that events at the level of single cells can be considered. Using discrete models, important events such as mutations can be taken into account as well as different phenotypic
properties. The introduction of discrete models have also led to the development of socalled "multiscale models", where intracellular events can be modeled using systems of ordinary differential equations and these can then be linked to cellular level parameters [35, 38] .
Hybrid continuum-discrete models have also been developed over the past 15
years or so to model another very important event in solid tumor growth and development -that of (tumor-induced) angiogenesis. The seminal paper of Anderson and Chaplain [38] initially considered a system of PDEs describing the spatio-temporal interactions of (tip) endothelial cells, n, extracellular matrix (represented by fibronectin), v and tumor angiogenic factor (TAF), a, as follows:
The endothelial cells perform a random walk as well as directed migration via chemotaxis in response to TAF gradients (e.g. VEGF) and haptotaxis, which is directed migration in response to fibronectin gradients in the extracellular matrix [40, 41] . The computational simulation results from the discrete version of the model that incorporated cellular-automata-like rules, such as capillary branching and anastomosis were able to reproduce branched, connected capillaries networks as observed in experimental papers (c.f. [42, 43] ), as can be seen from Figure 10 .
Such discrete models have now been developed to include the effects of blood flow within the capillaries and there currently exist several complementary models in the literature focusing on various aspects of tumor-induced angiogenesis and vascular tumor growth [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] . Additionally, these discrete angiogenesis models have been adapted and developed to model other systems where the development of blood vessels plays a critical role, such as wound healing [53, 54] and retinal development [55] .
Discussion
An increasing variety of mathematical models have made their way into cancer research over the past couple of decades. Herein we have illustrated how simple quantitative models are developed and compared with experimental data, and showed how they can be used to simulate complex biological processes and interactions. We have chosen seminal papers as examples, and for simplicity have had to leave out a large body of excellent mathematical modeling literature. The interested reader is referred to recent review articles and books that give a more inclusive overview of the state-of-the-art in cancer modeling [56] [57] [58] [59] .
